Sec Form 4 Filing - FISHER ITZHAK @ COMSCORE, INC. - 2021-12-16

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person FISHER ITZHAK 2. Issuer Name and Ticker or Trading Symbol COMSCORE, INC. [ SCOR] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) C/O COMSCORE, INC., 11950 DEMOCRACY DRIVE, STE. 600 3. Date of Earliest Transaction (MM/DD/YY) 12/16/2021 (Street) RESTON, VA20190 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 12/16/2021 A( 1 ) 89,888 A 89,888 I By Pereg Holdings, LLC Common Stock 126,969 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Option (right to buy) $ 0.82 12/16/2021 A( 2 ) 22,473 ( 3 ) 03/30/2027 Common Stock 22,473 ( 2 ) 22,473 D Stock Option (right to buy) $ 0.82 12/16/2021 A( 2 ) 67,416 ( 3 ) 03/30/2027 Common Stock 67,416 ( 2 ) 67,416 D Stock Option (right to buy) $ 0.88 12/16/2021 A( 2 ) 34,696 ( 3 ) 05/18/2029 Common Stock 34,696 ( 2 ) 34,696 D Stock Option (right to buy) $ 0.97 12/16/2021 A( 2 ) 33,044 ( 3 ) 05/26/2031 Common Stock 33,044 ( 2 ) 33,044 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other FISHER ITZHAK C/O COMSCORE, INC. 11950 DEMOCRACY DRIVE, STE. 600 RESTON, VA20190 X Signatures /s/ Ashley Wright, Attorney-in-Fact 12/20/2021 Signature of Reporting Person Date

Explanation of Responses:

( 1 )On December 16, 2021, pursuant to an Agreement and Plan of Merger (the "Merger Agreement") among the Company, Shareablee, Inc. ("Shareablee") and the other parties thereto, the Company acquired Shareablee (the "Transaction"). In connection with the Transaction, 272,027 shares of Shareablee preferred stock held by Pereg Holdings, LLC ("Pereg") were converted into the right to receive 89,888 shares of Company common stock. The Merger Agreement also provides that Pereg may receive up to $108,018 of deferred consideration, subject to the conditions and timing in the Merger Agreement, payable at the Company's option in any combination of cash and Company common stock, with any issuance of common stock to be based on the volume-weighted average trading price of the common stock for the 10 trading days prior to the date of release. The issuance was approved by the Company's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934 (the "Exchange Act"). ( 2 )In connection with the Transaction, options to purchase 68,007 shares of Shareablee common stock, 204,020 shares of Shareablee common stock, 105,000 shares of Shareablee common stock and 100,000 shares of Shareablee common stock held by the reporting person were converted into options to purchase 22,473 shares of Company common stock, 67,416 shares of Company common stock, 34,696 shares of Company common stock and 33,044 shares of Company common stock, respectively. The Merger Agreement also provides that the reporting person may receive up to $189,421 of deferred consideration, subject to the conditions and timing in the Merger Agreement, payable at the Company's option in any combination of cash and Company common stock, with any issuance of common stock to be based on the volume-weighted average trading price of the common stock for the 10 trading days prior to the date of release. The issuance was approved by the Company's board of directors pursuant to Exchange Act Rule 16b-3. ( 3 )Each option award vests and becomes exercisable 35% on June 15, 2022, an additional 50% on December 15, 2022, and the remaining 15% on June 15, 2023.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.